Expert US stock short interest and short squeeze potential analysis for identifying high-risk high-reward opportunities in the market. Our short interest data helps you understand bearish sentiment and potential catalysts for short covering rallies that can generate significant returns. We provide short interest data, days to cover analysis, and squeeze potential indicators for comprehensive coverage. Find short opportunities with our comprehensive short interest analysis and potential squeeze indicators for tactical trading.
Tempest Therapeutics Inc. (TPST), a clinical-stage oncology biotech firm, has seen notable price action in recent trading, with shares currently priced at $1.79, representing a 13.29% gain from prior closing levels. This analysis explores recent market context, key technical levels, and potential near-term scenarios for the stock, with no investment recommendations included. The recent uptick in TPST’s share price comes amid a broader shift in small-cap biotech trading sentiment, as investors re
Can Tempest Therapeutics (TPST) Stock Maintain Growth | Price at $1.79, Up 13.29% - Community Chart Signals
TPST - Stock Analysis
4830 Comments
570 Likes
1
Hilari
New Visitor
2 hours ago
Volume surges reflect heightened market activity, but long-term trends remain intact.
👍 276
Reply
2
Kymorra
Consistent User
5 hours ago
That moment when you realize you’re too late.
👍 251
Reply
3
Namia
Engaged Reader
1 day ago
The market demonstrates resilience, but investors should manage exposure to volatile segments.
👍 281
Reply
4
Laelia
Daily Reader
1 day ago
This hurts a little to read now.
👍 292
Reply
5
Ledell
Experienced Member
2 days ago
Market breadth supports current trend sustainability.
👍 223
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.